Insights On CONTRACT PHARMA MANUFACTURING
-
The Initial Contract With A CDMO
2/15/2024
Our expert panelist talks us through the best practices to put together your initial contract with a CDMO for development work on a biologics program.
-
CDMOs More Willing To Please
2/15/2024
Drug development and manufacturing veteran Perry Calias starts off our Outsourced Pharma Live event with a very positive assessment.
-
Pros And Cons Of Outsourcing To Taiwan: What You Need To Know
2/14/2024
Businesses adopt outsourcing to Asia as a pivotal strategy. While this entails both benefits and drawbacks, explore why teams should first necessitate careful consideration before making a decision.
-
The Cure For The Cure
2/14/2024
Traditional aseptic filling solutions can introduce contamination and variability. Learn about Cytiva's commitment to finding innovative solutions and improving patient outcomes in the field of medicine.
-
Current Trends And Innovations In The Development Of ADCs
2/14/2024
Learn the current innovations and trends in the development of ADCs focusing on three main aspects: linker technology, drug payloads, and manufacturing.
-
Consolidating The Supply Chain For mRNA
2/12/2024
Learn about the first end-to-end cGMP facility that was developed for mRNA manufacturing to address the shortage of CDMOs and the inadequate and inefficient supply chain options for sourcing GMP mRNA.
-
Combining Scientific Knowledge And Advanced Technology
2/9/2024
Your partner in contract production and development using the end-to-end business model. We specialize in the production of sterile biotechnological products in a manufacturing plant that meets the requirements of GMP.
-
Impact Of Glycosylation On The Effector Functions Of Monoclonal Antibodies
2/9/2024
In an example using rituximab and its biosimilars, explore the significance of minor differences of glycosylation in antibodies and its impact on their properties and functionality.
-
Mycoplasma Contamination In Biopharmaceutical Manufacturing
2/9/2024
Learn how following strict laboratory practices and conducting routine testing for Mycoplasma contamination using nucleic acid-based assays can help ensure the production of safe and high-quality biopharmaceutical products.
-
The Latest Trends In The Prevention And Treatment Of Cervical Cancer
2/8/2024
Unearth what immune checkpoint inhibitors are showing promise in treating cervical cancer and how advancements in these treatments paired with additional prevention strategies are improving patient outcomes.